What is the origin of the cells in a pigmented nodule with ulceration lateral to the nose in a 55-year-old male patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Origin of Cells in a Pigmented Nodule with Ulceration Lateral to the Nose

The pigmented nodule with ulceration lateral to the nose in this 55-year-old male patient most likely originates from melanocytes (option B).

Clinical Presentation Analysis

The key clinical features presented in this case include:

  • 55-year-old male patient
  • Small nodule lateral to the nose
  • Pigmentation of the nodule
  • Lateral ulceration
  • No lymph node involvement

These features strongly suggest a melanocytic lesion, specifically a potential melanoma. The combination of pigmentation and ulceration are particularly concerning for malignant melanoma.

Cellular Origin Explanation

Melanomas originate from melanocytes, which are neural crest-derived cells that normally reside in the basal layer of the epidermis 1. These cells are responsible for producing melanin, which gives pigmentation to the skin.

The evidence supporting melanocytes as the origin includes:

  1. Pigmentation: The presence of pigmentation in the nodule indicates melanin production, which is characteristic of melanocytic cells 2.

  2. Ulceration: Ulceration is a common feature in melanomas and represents a negative prognostic factor. The ESMO guidelines specifically mention ulceration as an important histological feature to report in melanoma diagnosis 2.

  3. Location: The face, including the area lateral to the nose, is a common site for melanoma development due to sun exposure, which is a major risk factor for melanocytic transformation 2, 3.

Differential Diagnosis

While considering the origin of the cells in this lesion:

  • Keratinizing cells (option A): These would typically present as squamous cell carcinoma, which can be pigmented but is less commonly so compared to melanoma. Squamous cell carcinomas arise from keratinocytes in the epidermis 3.

  • Non-keratinizing cells (option C): This is a less specific term and could refer to various cell types, but does not typically describe the origin of pigmented lesions.

  • Pluripotent cells (option D): While melanocytes do originate from pluripotent neural crest cells during embryonic development, the actual tumor would arise from differentiated melanocytes, not from pluripotent cells directly 1.

Diagnostic Approach

The British Journal of Cancer guidelines recommend a complete excisional biopsy for suspicious pigmented lesions 2, 3. The histopathological examination should include:

  • Confirmation of melanocytic origin
  • Maximum tumor thickness (Breslow index)
  • Presence/absence of ulceration
  • Level of invasion (Clark level)
  • Margin status

Immunohistochemistry may be necessary to confirm the melanocytic nature of the lesion, particularly if it is non-pigmented or has unusual presentation 2, 3.

Clinical Implications

If this lesion is indeed a melanoma originating from melanocytes, the prognosis and treatment will depend on:

  • Breslow thickness (the most powerful prognostic factor) 2
  • Presence of ulceration (which worsens prognosis) 2
  • Clark level (especially important for thin melanomas) 2

Treatment would typically involve wide excision with margins determined by the Breslow thickness, and possibly sentinel lymph node biopsy depending on the depth of invasion 2, 3.

Conclusion

Based on the clinical presentation of a pigmented, ulcerated nodule in a sun-exposed area, the most likely cellular origin is melanocytes (option B), which would be consistent with a diagnosis of melanoma.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Skin Cancer Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.